Cellular growth inhibition by IGFBP-3 and TGF-β1 requires LRP-1

FASEB Journal

Volumn 17, Issue 14, 2003, Pages 2068-2081

  Huang, Shuan Shian ^a   Ling, Thai Yen ^b   Tseng, Wen Fang ^b   Huang, Yen Hwa ^c   Tang, Fen Mei ^b   Leal, Sandra M ^a   Huang, Jung San ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Carcinogenesis; Epithelial cells; Growth inhibition; IGFBP 3 receptor; Type V TGF receptor

Indexed keywords

CELL SURFACE RECEPTOR; COMPLEMENTARY DNA; IODINE 125; LIPOPROTEIN RECEPTOR; LIPOPROTEIN RECEPTOR RELATED PROTEIN 1; RECEPTOR SUBTYPE; RNA; SOMATOMEDIN BINDING PROTEIN 3; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRITIUM; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CARCINOGENESIS; CELL GROWTH; CONTROLLED STUDY; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; ISOTOPE LABELING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MUTAGENESIS; NORTHERN BLOTTING; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; CARCINOMA; CATTLE; CELL DIVISION; CELL LINE, TUMOR; CELLS, CULTURED; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LDL-RECEPTOR RELATED PROTEIN 1; LIVER; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; PRECIPITIN TESTS; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

BOVINAE;

EID: 0242526800     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.03-0256com     Document Type: Article

References (52)

1. Roberts, A. B., and Sporn, M. B. (1990) The transforming growth factor-βs. (Sporn, M. B., and Roberts, A. B., eds) In Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors, pp. 419-472, Springer-Verlag, New York
2. Massagué, J. (1990) The transforming growth factor-β family. Annu. Rev. Cell Biol. 6, 597-641
3. Roberts, A. B. (1998) Molecular and cell biology of TGF-β. Miner Electrol. Metab. 24, 111-119
4. Massagué, J. (1992) Receptors for the TGF-β family. Cell 69, 1067-1070
5. Yingling, J. M., Wang, X. F., and Bassing, C. H. (1995) Signaling by the transforming growth factor-β receptors. Biochim. Biophys. Acta 1242, 115-136
6. Heldin, C. H., Miyazono, K., and ten Dijke, P. (1997) TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature (London) 300, 465-471
7. Massagué, J. (1998) TGF-β signal transduction. Annu. Rev. Biochem. 67, 753-791
8. Blobe, G. C., Schiemann, W. P., Pepin, M. C., Beauchemin, M., Moustakas, A., Lodish, H. F., and O'Connor-McCourt, M. D. (2001) Functional roles for the cytoplasmic domain of the type III transforming growth factor β receptor in regulating transforming growth factor β signaling. J. Biol. Chem. 276, 24627-24637
9. Blobe, G. C., Liu, X., Fang, S. J., How, T., and Lodish, H. F. (2001) A novel mechanism for regulating transforming growth factor β (TGF-β) signaling. Functional modulation of type III TGF-β receptor expression through interaction with the PDZ domain protein, GIPC. J. Biol. Chem. 276, 39608-39617
10. Eickelberg, O., Centrella, M., Reiss, M., Kashgarian, M., and Wells, R. G. (2002) β-Glycan inhibits TGF-β signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter βglycan function. J. Biol. Chem. 277, 823-829
11. Moustakas, A., Takumi, T., Lin, H.-Y., and Lodish, H. F. (1995) GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor β and activin A. J. Biol. Chem. 270, 765-769
12. Yamashita, H., Okadome, T., Franzen, P., ten Dijke, P., Heldin, C.-H., and Miyazono, K. (1995) A rat pituitary tumor cell line (GH3) expresses type I and type II receptors and cell surface binding protein(s) for transforming growth factor β. J. Biol. Chem. 270, 770-774
13. O'Grady, P., Huang, S. S., and Huang, J. S. (1991) Expression of a new type high molecular weight receptor (type V receptor) of transforming growth factor β in normal and transformed cells. Biochem. Biophys. Res. Commun. 179, 378-385
14. Leal, S. M., Liu, Q., Huang, S. S., and Huang, J. S. (1997) The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor. J. Biol. Chem. 272, 20572-20576
15. Leal, S. M., Huang, S. S., and Huang, J. S. (1999) Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-β receptor in mink lung epithelial cells. J. Biol. Chem. 274, 6711-6717
16. Wu, H. B., Kumar, A., Tsai, W. C., Mascarenhas, D., Healey, J., and Rechler, M. M. (2000) Characterization of the inhibition of DNA synthesis in proliferating mink lung epithelial cells by insulin-like growth factor binding protein-3. J. Cell. Biochem. 77, 288-297
17. Taipale, J., and Keski-Oja, J. (1996) Hepatocyte growth factor releases epithelial and endothelial cells from growth arrest induced by transforming growth factor-β1. J. Biol. Chem. 271, 4342-4348
18. Wang, J., Han, W., Zborowska, E., Liang, J., Wang, X., Willson, J. K., Sun, L., and Brattain, M. G. (1996) Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells. J. Biol. Chem. 271, 17366-17371
19. Hocevar, B. A., and Howe, P. H. (1998) Mechanisms of TGF-β-induced cell cycle arrest. Miner. Electrol. Metab. 24, 131-135
20. 1, in a thyroid carcinoma cell line with functional type I and type II TGF-β receptors and Smad proteins, suggests a novel mechanism for TGF-β insensitivity in carcinoma cells. Mol. Cell. Endocrinol. 153, 79-90
21. Petritsch, C., Beug, H., Balmain, A., and Oft, M. (2000) TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev. 14, 3093-3101
22. Fink, S. P., Swinler, S. E., Lutterbaugh, J. D., Massagué, J., Thiagalingam, S., Kinzler, K. W., Vogelstein, B., Willson, J. K., and Markowitz, S. (2001) Transforming growth factor-β-induced growth inhibition in a Smad4 mutant colon adenoma cell line. Cancer Res. 61, 256-260
23. Moustakas, A., Pardali, K., Gaal, A., and Heldin, C. H. (2002) Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunol Lett. 82, 85-91
24. Liu, Q., Huang, S. S., and Huang, J. S. (1997) Function of the type V transforming growth factor β receptor in transforming growth factor β-induced growth inhibition of mink lung epithelial cells. J. Biol. Chem. 272, 18891-18895
25. Herz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohl, H., and Stanley, K. K. (1988) Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7, 4119-4127
26. Boensch, C., Huang, S. S., Connolly, D. T., and Huang, J. S. (1999) Cell surface retention sequence binding protein-1 interacts with the v-sis gene product and platelet-derived growth factor β-type receptor in simian sarcoma virus-transformed cells. J. Biol. Chem. 274, 10582-10589
27. Herz, J., and Strickland, D. K. (2001) LRP-1: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108, 779-784
28. O'Grady, P., Kuo, M. D., Baldassare, J. J., Huang, S. S., and Huang, J. S. (1991) Purification of a new type high molecular weight receptor (type V receptor) of transforming growth factor β (TGF-β) from bovine liver. Identification of the type V TGF-β receptor in cultured cells. J. Biol. Chem. 266, 8583-8589
29. Huang, S. S., Liu, Q., Johnson, F. E., Konish, Y., and Huang, J. S. (1997) Transforming growth factor β peptide antagonists and their conversion to partial agonists. J. Biol. Chem. 272, 27155-27159
30. Willnow, T. E., and Herz, J. (1994) Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A. Evidence that this protein is required for uptake and degradation of multiple ligands. J. Cell Sci. 107, 719-726
31. FitzGerald, D.J., Fryling, C. M., Zdanovsky, A., Saelinger, C. B., Kounnas, M., Winkles, J. A., Strickland, D., and Leppla, S. (1995) Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein. J. Cell Biol. 129, 1533-1541
32. O'Grady, P., Liu, Q., Huang, S. S., and Huang, J. S. (1992) Transforming growth factor β (TGF-β) type V receptor has a TGF-β-stimulated serine/threonine-specific autophosphorylation activity. J. Biol. Chem. 267, 21033-21037
33. 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265, 17401-17404
34. 2-macroglobulin receptor. J. Biol. Chem. 266, 21232-21238
35. Bu, G. (1998) Receptor-associated protein: a specialized chaperone and antagonist for members of the LDL receptor gene family. Curr. Opin. Lipidol. 9, 149-155
36. Krieger, M., and Herz, J. (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP-1). Annu. Rev. Biochem. 63, 601-637
37. Strickland, D. K., Gonias, S. L., and Argraves, W. S. (2002) Diverse roles for the LDL receptor family. Trends Endocrinol. Metab. 13, 66-74
38. 2-macroglobulin complex is a latent form of transforming growth factor β. J. Biol. Chem. 263, 1535-1541
39. 2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein on rat liver parenchymal cells by the 39-kDa receptor-associated protein leaves the interaction of β-migrating very-low-density lipoprotein with the lipoprotein remnant receptor unaffected. Eur. J. Biochem. 242, 703-711
40. Laiho, M., Weis, M. B., and Massagué, J. (1990) Concomitant loss of transforming growth factor (TGF)-β receptor types I and 11 in TGF-β-resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem. 265, 18518-18524
41. Howell, B. W., and Herz, J. (2001) The LDL receptor gene family: signaling functions during development. Curr. Opin. Neurobiol. 11, 74-81
42. Lutz, C., Nimpf, J., Jenny, M., Boecklinger, K., Enzinger, C., Utermann, G., Baier-Bitterlich, G., and Bair, G. (2002) Evidence of functional modulation of the MEKKK/JNK/cJun signaling cascade by the low density lipoprotein receptor-related protein (LRP-1). J. Biol. Chem. 277, 43143-43151
43. Pellheiter, S. G., Mitchell, H., Garamszegi, N., Edens, M., Dore, J. J., Jr., and Leof, E. B. (2002) Internalization-dependent and -independent requirements for transforming growth factor β receptor signaling via the Smad pathway. Mol. Cell Biol. 22, 4750-4759
44. Ravitz, M. J., and Wenner, C. E. (1997) Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-β. Adv. Cancer Res. 71, 165-207
45. Derrynck, R., Akhurst, R. J., and Balmain, A. (2001) TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29, 117-129
46. Wakefield, L. M., and Roberts, A. B. (2002) TGF-βsignaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12, 22-29
47. 2-macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines. J. Biol. Chem. 254, 5155-5160
48. 2-macroglobulin receptor/LRP-1. A growth regulatory axis. Ann. N.Y. Acad. Sci. 737, 273-290
49. 2-macroglobulin receptor/low density lipoprotein receptor-related protein on surfaces of tumour cells: a study using flow cytometry. Cancer Lett. 111, 199-205
50. Liu, C.-X., Musco, S., Lisitsina, N. M., Forgacs, E., Minna, J. D., and Lisitsyn, N. A. (2000) LRP-DIT, a putative endocytic receptor gene, is frequently inactivated in nonsmall cell lung cancer cell lines. Cancer Res. 60, 1961-1967
51. 2-macroglobulin receptor in human malignant astrocytomas. Cancer Res. 57, 2799-2805
52. Koong, A. C., Denko, N. C., Hudson, K. M., Schindler, C., Swiersz, L., Koch, C., Evans, S., Ibrahim, H., Le, Q. T., Terris, D. J., et al. (2000) Candidate genes for the hypoxic tumor phenotype. Cancer Res. 60, 883-887